Today: 19 May 2026
Browse Category

TSX:WEED 6 December 2025 - 24 December 2025

Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth shares closed at $1.40 on Dec. 23, up 6.06%, after heavy trading and sharp swings throughout December. The volatility followed a Dec. 18 White House executive order directing marijuana rescheduling from Schedule I to III. Trading volume spiked to over 216 million shares on Dec. 18, with implied volatility near 143%. U.S. exchanges operated a shortened session on Dec. 24.
Canopy Growth Corporation Stock (CGC) Jumps on Trump Marijuana Rescheduling Report — News, Forecasts, and What Investors Are Watching (Dec. 12, 2025)

Canopy Growth Corporation Stock (CGC) Jumps on Trump Marijuana Rescheduling Report — News, Forecasts, and What Investors Are Watching (Dec. 12, 2025)

Canopy Growth shares jumped about 21% in premarket trading Friday after reports said President Trump is expected to direct federal agencies to reclassify marijuana as a Schedule III drug. The move, first reported by the Washington Post and cited by Reuters, triggered a surge across US-listed cannabis stocks. No final decision has been made, according to a White House official.
Canopy Growth (CGC) Stock Outlook December 2025: Debt Prepayment, Lawsuit Pressure and a High‑Risk Turnaround

Canopy Growth (CGC) Stock Outlook December 2025: Debt Prepayment, Lawsuit Pressure and a High‑Risk Turnaround

Canopy Growth shares closed at $1.15 on December 5, down 4.96%, but remain up about 13–14% over the last 10 sessions. Q2 FY2026 net revenue rose 6% to C$66.7 million, with gross margin improving to 33%. Net loss narrowed sharply to C$1.6 million from C$131.6 million a year earlier. The company ended the quarter with C$298 million in cash, exceeding its total debt.

Stock Market Today

  • Billionaire Israel Englander Chooses Micron Over SanDisk for AI Memory Investment
    May 19, 2026, 8:37 AM EDT. Billionaire investor Israel Englander, worth approximately $26.5 billion, favors Micron Technology over SanDisk for investment in the AI memory sector. Englander, founder of Millennium Management, sees Micron's advanced memory solutions as better positioned to capitalize on the increasing demand for AI-related semiconductor components. The investment highlights a critical trend as AI applications drive growth in memory technologies crucial for data processing. Englander's preference signals confidence in Micron's potential over SanDisk, a key player in flash memory storage. This move could influence investor sentiment towards AI-focused semiconductor stocks amid rising interest in AI infrastructure.

Latest articles

Wellgistics Health Stock Doubled — Now WGRX Faces Its Real Test

Wellgistics Health Stock Doubled — Now WGRX Faces Its Real Test

19 May 2026
Wellgistics Health shares fell 21.1% to $0.14 in premarket trading Tuesday after more than doubling Monday. The company delayed its quarterly report, withdrew proxy materials, and is reviewing potential strategic transactions. First-quarter results are due after the market closes. The moves follow a non-binding $15 million acquisition proposal for WellCare Today.
Roblox Stock Moves Up Early, Safety Issues Still Linger

Roblox Stock Moves Up Early, Safety Issues Still Linger

19 May 2026
Roblox shares traded at $47.41 in early New York hours Tuesday, extending gains after third-party data showed a week-over-week rise in concurrent users. Needham maintained its Buy rating and $60 target. The stock remains pressured by a lowered 2026 bookings outlook, tied to new safety and age-check measures. Roblox reported Q1 revenue of $1.4 billion and bookings of $1.7 billion.
Amer Sports Rises Premarket on Salomon Strength

Amer Sports Rises Premarket on Salomon Strength

19 May 2026
Amer Sports raised its 2026 sales, margin, and profit outlook after first-quarter revenue jumped 32% to $1.95 billion, beating forecasts. Shares rose 4.18% in premarket trading to $34.54. Adjusted earnings reached 38 cents a share, above analysts’ estimates. Growth was led by Arc’teryx, Salomon softgoods, and Wilson Tennis 360.

Popular

Figma shares test rebound as AI bet delivers

Figma shares test rebound as AI bet delivers

18 May 2026
Figma traded at $23.20 Monday afternoon, valuing the company at $12.1 billion. First-quarter revenue jumped 46% to $333.4 million, and the company raised its 2026 revenue forecast to up to $1.428 billion. Paid customers rose 54% to about 690,000. Figma posted a GAAP net loss of $142.4 million but reported $56.5 million in non-GAAP net income.
Go toTop